Search filters

List of works by Diana Hernández-Romero

An insight of novel pharmacological therapies in hypertrophic cardiomyopathy.

scientific article published on July 2011

Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis

scientific article published on 09 January 2009

Bleeding Risk Prediction in Patients With Dual Antiplatelet Therapy Undergoing Coronary Artery Bypass Grafting Surgery Using a Rapid Point-of-Care Platelet Function Test

scientific article published on 01 December 2018

CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis.

scientific article published on September 2010

CALU polymorphism A29809G affects calumenin availability involving vascular calcification

scientific article published on 28 March 2015

Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy.

scientific article published on 23 December 2015

Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy

scientific article published on 13 June 2011

Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation

scientific article published on 18 October 2012

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

scientific article published on 30 January 2017

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

scientific article published on 27 December 2014

Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

scientific article published on 17 April 2019

Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation.

scientific article published on 12 January 2017

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

scientific article published on 04 August 2010

Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy

scientific article published on 15 September 2011

High-sensitivity troponin T and copeptin in non-ST acute coronary syndromes: implications for prognosis and role of hsTnT and copeptin in non-STEACS.

scientific article

High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery.

scientific article published on 25 October 2013

Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches

scientific article

Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy

scientific article published on 20 April 2011

Implications of pharmacogenetics for oral anticoagulants metabolism.

scientific article published in July 2009

Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study

scientific article published on 26 June 2011

Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification

scientific article published in August 2018

Interleukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST-segment elevation acute coronary syndromes

scientific article published on 8 December 2012

Lone atrial fibrillation - a diagnosis of exclusion

scientific article published on January 2015

Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion.

scientific article published on 14 January 2016

New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?

scientific article

Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy

scientific article published on 13 February 2010

Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.

scientific article

Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold.

scientific article published on 2 June 2016

Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.

scientific article published on 18 May 2012

Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy

scientific article published on 01 December 2010

Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.

scientific article published on 29 January 2013

Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin

scientific article published on 28 April 2014

Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

scientific article published on 29 June 2010

TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy

scientific article published on 7 January 2015

The prognostic role of the adiponectin levels in atrial fibrillation

scientific article published on 20 December 2012

The prognostic value of biomarkers after a premature myocardial infarction

scientific article published on 17 March 2009

Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery

scientific article published on 12 November 2015

Paulina is supported by:

About Paulina

Help